|

Rosiglitazone Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Avandia

Pipeline

Phase 2: 1

Top Sponsors

  • Dan Zandberg1

Indications

  • Liver Disease1
  • Microsatellite Instability-High Solid Malignant Tumor1
  • Gastric Adenocarcinoma1
  • HNSCC1
  • Esophageal Adenocarcinoma1

Pittsburgh, Pennsylvania1 trial

Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies

UPMC Hillman Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.